10-Q · May 6, 2026
Celanese Corporation reported Q1 2026 earnings that reflected a slight decline in revenue compared to the previous year, primarily driven by decreased sales in the Acetyl Chain segment. However, operating profit saw a…
Earnings analysis · 10-Q
CE earnings analysis
Filed November 3, 2026 · Our reading of the company's report
The latest report
Celanese delivered a mixed third quarter: revenue increased 6% year over year to $2,556 million and operating profit recovered to $198 million, but quarterly revenue and margins declined sequentially and Engineered…
Read full summary
Celanese delivered a mixed third quarter: revenue increased 6% year over year to $2,556 million and operating profit recovered to $198 million, but quarterly revenue and margins declined sequentially and Engineered Materials volume remained weak. Acetyl Chain pricing drove growth, while raw-material costs, restructuring and higher spending limited profit conversion. Liquidity improved through $823 million of year-to-date operating cash flow, asset-sale proceeds and lower debt, but working-capital use, weakened demand and a narrow Engineered Materials impairment cushion remain significant risks.
From revenue to operating profit
Where each $100 of revenue went in this report.
Cost of sales, operating expenses, and what remained. Figures are rounded to whole dollars.
Where revenue came from
The business segments reported by the company.
Shares of the segments disclosed in this filing, largest first.
What stood out
-
Revenue grew year over year
Q3 net sales were $2,556 million, up $137 million or 6% from $2,419 million a year earlier, but down approximately 7% from $2,750 million in Q2 2026. Gross margin was 21.1%, down from 21.5% in Q3 2025 and 22.5% in Q2 2026.
-
Operating results normalized
Operating profit was $198 million versus a $1,275 million loss in Q3 2025, producing a 7.7% operating margin versus negative 52.7%. The year-over-year improvement was substantially driven by the absence of $1.5 billion of prior-year impairment-related charges.
-
Acetyl Chain led growth
Acetyl Chain sales rose 13.9% to $1,209 million and operating profit increased 4.4% to $141 million. Higher pricing contributed 14%, although higher ethylene and methanol costs, $23 million of additional spending and $20 million of restructuring charges pressured earnings.
-
Debt reduction improved liquidity
Cash and equivalents increased $99 million to $1,362 million at September 30, 2026, while total debt declined to $11,545 million from $12,598 million at year-end 2025. The company also had $1.75 billion available under its U.S. revolver and $75 million under China revolving facilities.
-
Asset sales supported cash
The company generated $823 million of operating cash flow in the first nine months, compared with $894 million a year earlier. Cash flow benefited from a $493 million Micromax sale, while the sale also generated a $50 million gain and supported deleveraging.
-
Engineered Materials recovered
Engineered Materials operating profit was $161 million versus a $1,327 million loss in the prior-year quarter, but segment sales declined 1.2% to $1,368 million as volume fell 6%, primarily due to the Micromax divestiture.
What to watch
-
Working capital is consuming cash
Operating cash flow fell $71 million to $823 million for the first nine months, while trade working capital increased $346 million. Management attributed the working-capital use primarily to higher inventories from pricing and raw-material costs and higher receivables from increased sales and collection timing.
-
Elevated leverage limits flexibility
Leverage remains material at $11,545 million of total debt versus $1,362 million of cash. Management says weakened demand is expected to adversely affect near-term cash generation, and the company has paused share repurchases while evaluating further cash-conservation measures.
-
Impairment cushion remains narrow
The Engineered Materials reporting unit exceeded carrying value by only approximately 8% in the annual impairment test. A 1% increase in the discount rate would reduce that cushion to approximately 4%; certain indefinite-lived intangible assets had only 1% to 6% excess fair value, and a 1% discount-rate increase would produce a $59 million impairment.
-
Input costs and restructuring pressure margins
Acetyl Chain operating profit increased only $6 million despite a $148 million sales increase, as higher ethylene and methanol costs, $23 million of higher spending, $20 million of restructuring charges and $18 million of accelerated depreciation offset pricing benefits.
-
Tariff and demand uncertainty
The company highlights tariffs and potential future tariff actions as a business risk and says it continues to assess mitigation. Q3 pricing contributed 10% to consolidated sales growth, indicating that reported growth was substantially price-driven while total volume declined 4%.
-
Open tax inquiries create exposure
The company is subject to Chinese tax inquiries for taxable years 2021 through 2026 concerning the 5% treaty withholding rate versus the standard 10% rate. Management says any unfavorable resolution could require material adjustments to income tax expense and cash flows.
Management's outlook
The 10-Q provides no numeric revenue or EPS guidance. Management expects total 2026 capital expenditures of approximately $300 million to $350 million and believes liquidity will be sufficient for operational, capital investment and financial obligations for the foreseeable future.
Earlier filings 1
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.